 Home > Biochemistry News > Biotechnology News > Pfizer's JAK1 inhibitor receives EU CHMP support and is expected to be approved this year for the treatment of atopic dermatitis

Pfizer's JAK1 inhibitor receives EU CHMP support and is expected to be approved this year for the treatment of atopic dermatitis

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

paint skin tones

liquid skin

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 15, 2021, Pfizer announced that the European Medicines Agency (EMA) Committee for Human Medicines (CHMP) has issued a positive opinion on abrocitinib and recommends approval for the marketing of abrocitinib

Atopic dermatitis is a chronic skin disease characterized by skin inflammation and skin barrier defects.

Abrocitinib is an oral JAK1 inhibitor

▲The molecular structure of Abrocitinib (picture source: Edgar181, Public domain, via Wikimedia Commons)

This positive opinion is based on the results of 5 phase 3 clinical trials and a long-term extended clinical study involving more than 3100 patients

Reference materials:

[1] Pfizer's Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.